GGrantIndex
Sort

82,697 grants matching vaccine development

ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER

$679,195
Novarx Corporation · R44 · FY2003 · CA

Impact of Pregnancy on Tuberculosis

$679,173
Jerrold J. Ellner · Boston Medical Center · R01 · FY2016 · AI

Biochemical Mechanism of HIV DNA Integration

$679,163
Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2023 · AI

Biochemical Mechanism of HIV DNA Integration

$679,163
Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2022 · AI

Biochemical Mechanism of HIV DNA Integration

$679,163
Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2021 · AI

Biochemical Mechanism of HIV DNA Integration

$679,163
Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2024 · AI

Implementation of a Sexual Health Intervention for YMSM in Two Vietnamese Cities

$679,158
Lloyd A Goldsamt · National Development And Research Institutes, Inc. · R01 · FY2012 · DA

Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies

$679,142
David Nemazee · Scripps Research Institute, The · R01 · FY2022 · AI

Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies

$679,142
David Nemazee · Scripps Research Institute, The · R01 · FY2019 · AI

Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies

$679,142
David Nemazee · Scripps Research Institute, The · R01 · FY2021 · AI

Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies

$679,142
David Nemazee · Scripps Research Institute, The · R01 · FY2020 · AI

Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus

$679,126
Gregg A Dean · Colorado State University · R01 · FY2022 · AI

A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites

$679,120
Ma Luo · University Of Manitoba · R01 · FY2015 · AI

Development of next generation 2HG and metabolic MR imaging for precision oncology of mutant IDH and wildtype glioma patients

$679,074
Ovidiu C Andronesi · Massachusetts General Hospital · R01 · FY2025 · CA

Collective Responses to Malaria Vaccination

$679,001
Kenneth D Stuart · Seattle Children'S Hospital · U01 · FY2025 · AI

ADHERENCE BLOCKING VACCINE FOR AMEBIASIS

$678,919
University Of Virginia Charlottesville · P01 · FY2003 · AI

Frequency and phenotype of Fel d 1-specific T cells after peptide therapy

$678,916
Mark Larche · Mcmaster University · U19 · FY2012 · AI

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

$678,903
Harel Dahari · Loyola University Chicago · R01 · FY2025 · AI

Targeting RIPK3 in Flu-Associated Lung Injury

$678,878
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2020 · AI

Molecular Mechanisms of Human Long-lived Plasma Cell Generation in the Bone Marrow and Spleen

$678,860
Frances Eun-Hyung Lee · Emory University · U01 · FY2025 · AI

Pneumococcal Biofilms in Otitis Media

$678,843
Allegheny-Singer Research Institute · R01 · FY2005 · DC

A Novel Recombinant Protein Vaccine Against Ricin Toxin

$678,824
University Of Texas Sw Med Ctr/Dallas · U01 · FY2005 · AI

Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa

$678,745
Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AI

Regulation of memory T cell differentiation and long-term maintenance

$678,728
Ananda W Goldrath · University Of Florida · P01 · FY2024 · AI

Discovery of SARS-CoV-2 antivirals using a replicon assay

$678,703
Stefan G Sarafianos · Emory University · R01 · FY2024 · AI